Read + Share
Amedeo Smart
Independent Medical Education
Mehta-Dhand S, Hamidi N, Clarke AN, Hoentjen F, et al. EFFECTIVENESS OF RISANKIZUMAB AFTER USTEKINUMAB FAILURE IN CROHN'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY. Gastroenterology 2026 May 8:S0016-5085(26)06830.PMID: 42107795
Email
LinkedIn
Privacy Policy